Does IRBESARTAN Cause Product use issue? 46 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 46 reports of Product use issue have been filed in association with IRBESARTAN (Irbesartan). This represents 0.5% of all adverse event reports for IRBESARTAN.
46
Reports of Product use issue with IRBESARTAN
0.5%
of all IRBESARTAN reports
1
Deaths
39
Hospitalizations
How Dangerous Is Product use issue From IRBESARTAN?
Of the 46 reports, 1 (2.2%) resulted in death, 39 (84.8%) required hospitalization, and 15 (32.6%) were considered life-threatening.
Is Product use issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IRBESARTAN. However, 46 reports have been filed with the FAERS database.
What Other Side Effects Does IRBESARTAN Cause?
Acute kidney injury (1,361)
Fall (795)
Hypotension (686)
Nausea (533)
Drug ineffective (532)
Malaise (488)
Hyponatraemia (485)
Fatigue (483)
Blood pressure increased (477)
Hyperkalaemia (454)
What Other Drugs Cause Product use issue?
INFLIXIMAB (12,752)
DUPILUMAB (10,575)
POLYETHYLENE GLYCOL 3350 (9,432)
METHOTREXATE (8,185)
DICLOFENAC (8,009)
RITUXIMAB (6,948)
ADALIMUMAB (6,379)
ETANERCEPT (6,062)
TOCILIZUMAB (5,944)
ABATACEPT (5,915)
Which IRBESARTAN Alternatives Have Lower Product use issue Risk?
IRBESARTAN vs IRINOTECAN
IRBESARTAN vs IRON
IRBESARTAN vs IRON DEXTRAN
IRBESARTAN vs IRON ISOMALTOSIDE 1000
IRBESARTAN vs IRON POLYMALTOSE